Quantitative Investment Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1445911 CHARLOTTESVILLE, VA

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,143,721

+$2,485,784 QoQ

Shares Held

8,342

+128.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#512

of 1,732 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Quantitative Investment Management, LLC holds $20,430,992 across 8 Biotechnology names. VRTX ranks #2 (20.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	13,499	$8,417,166
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	8,342	$4,143,721
3	ALNY	Alnylam Pharmaceuticals, Inc.	7,981	$2,402,520
4	INSM	INSMED Inc	15,894	$1,694,618
5	VKTX	Viking Therapeutics, Inc.	41,416	$1,615,638
6	HALO	Halozyme Therapeutics, Inc.	16,631	$1,301,708
7	ASND	Ascendis Pharma A/S	1,985	$529,439
8	RXRX	Recursion Pharmaceuticals, Inc.	88,878	$326,182

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,143,721	8,342	+128.1%	Shares	Sole	2026-08-14
2025-12-31	$1,657,937	3,657	+118.7%	Shares	Sole	2026-02-17
2025-09-30	$654,822	1,672	-88.9%	Shares	Sole	2025-11-13
2025-03-31	$7,270,845	14,997	+4.8%	Shares	Sole	2025-05-14
2024-06-30	$6,705,508	14,306	-31.2%	Shares	Sole	2024-08-14
2024-03-31	$8,692,099	20,794	-61.3%	Shares	Sole	2024-05-15
2023-12-31	$21,847,551	53,694	+1589.0%	Shares	Sole	2024-02-13
2023-09-30	$1,105,465	3,179	-65.3%	Shares	Sole	2023-11-14
2023-06-30	$3,221,032	9,153	-17.2%	Shares	Sole	2023-08-14
2023-03-31	$3,482,468	11,053	-48.9%	Shares	Sole	2023-05-15
2021-12-31	$4,748,191	21,622	+14.5%	Shares	Sole	2022-02-14
2020-06-30	$5,479,891	18,876	+248.6%	Shares	Sole	2020-08-14
2020-03-31	$1,288,499	5,415	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.